Shares of Tylenol maker Kenvue bounced back sharply before the opening bell a day after President Donald Trump promoted ...

Analysts suggest strong support levels for Nifty 50, while several stocks, including Usha Martin and Ashok Leyland, are ...

U.S. stocks fell from record highs Tuesday after Federal Reserve Chair Jerome Powell spoke for the first time since the ...

Discover how U.S. moves toward mineral independence with potential Trump investment in Lithium Americas Corp. amid rising ...

Donald Trump's net worth reaches $7.3 billion in 2025, as Forbes highlights his major gains from crypto, real estate, and ...

U.S. stock indexes are slipping as Wall Street takes a moment following a relentless rally. The S&P 500 fell 0.5% Tuesday.

NEW YORK (AP) — U.S. stock indexes are holding near their record heights on Tuesday as Wall Street takes a moment following a ...

Shares of oil companies rose after President Trump dismissed efforts to fight climate change, advocating for countries in Western Europe to pivot back to fossil fuels. Halliburton's stock climbed 8.7% ...

The Wall Street Journal reported Monday that Spitznagel, dubbed the “Black Swan” investor, is predicting a short-term economic rally turned into a market crash akin to one of the most famous stock ...

Nvidia announced a landmark partnership with OpenAI that will see it invest up to $100 billion in OpenAI's new AI models, ...

Shares of Kenvue Inc. sank 7.5 percent on Monday as President Trump linked use of the painkiller by pregnant woman with autism in children.

Shares of Kenvue, the maker of Tylenol, rebounded Tuesday in premarket trading after sinking Monday ahead of President Trump's press conference about autism. The stock was up 6% to $17.98 in premarket ...